Virginia Navarro

Dr. Virginia Navarro

University of the Basque Country (UPV-EHU)
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
ACAner Cardo
Aner Cardo
ICItziar Churruca
Itziar Churruca
ALArrate Lasa
Arrate Lasa
VNVirginia Navarro
Virginia Navarro
MVMaialen Vazquez-Polo
Maialen Vazquez-Polo
ILIDOIA LARRECHI LAMELAS
IDOIA LARRECHI LAMELAS
Celiac disease (CD) is a chronic autoimmune disorder of the small intestine, whose only effective treatment is a gluten-free diet (GFD). It is characterized by the atrophy of the intestinal villi that leads to altered nutrient absorption. This study describes the nutritional imbalances which may be found in adults with CD following a GFD. During the first year of treatment, deficiencies will overcome as the intestinal mucosa recovers. Thus, biochemical data will show this progression, together with the decrease in symptoms. In contrast, in the long term, when a strict GFD is followed and mucosal recovery is achieved, analyzing nutrient intake makes more sense. Macronutrient consumption is characterized by its low complex carbohydrate and fiber intakes, and high fat (especially SFA) and sugar intakes. This profile has been related to the consumption of GFP and their nutritional composition, in addition to unbalanced dietary habits. The most notable deficiencies in micronutrients are usually those of iron, calcium and magnesium and vitamin D, E and some of group B. It is necessary to follow up patients with CD and to promote nutritional education among them, since it could help not only to achieve a gluten free but also a balanced diet.

1 April 2005 in Nutrition
Verified
Journal Article
Closed access
MMMaría Teresa Macarulla
María Teresa Macarulla
AFAlfredo Fernandez-Quintela
Alfredo Fernandez-Quintela
AZAmaia Zabala
Amaia Zabala
VNVirginia Navarro
Virginia Navarro
EEEnrique Echevarría
Enrique Echevarría
MPMaria P. Portillo
Maria P. Portillo

1 September 2003 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
VNVirginia Navarro
Virginia Navarro
AZA. Zabala
A. Zabala
MMM. T. Macarulla
M. T. Macarulla
AFAlfredo Fernandez-Quintela
Alfredo Fernandez-Quintela
VRV. M. Rodríguez
V. M. Rodríguez
MPM. P. Portillo
M. P. Portillo

1 March 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ARAntonio Romero-Ruiz
Antonio Romero-Ruiz
LBLucía Bautista
Lucía Bautista
VNVirginia Navarro
Virginia Navarro
AHAntonio Heras-Garvín
Antonio Heras-Garvín
RMRosana March-Díaz
Rosana March-Díaz
APAlberto Pascual
Alberto Pascual
Early adaptive responses to hypoxia are essential for cell survival, but their nature and underlying mechanisms are poorly known. We have studied the post-transcriptional changes in the proteome of mammalian cells elicited by acute hypoxia and found that phosphorylation of eukaryotic elongation factor 2 (eEF2), a ribosomal translocase whose phosphorylation inhibits protein synthesis, is under the precise and reversible control of O(2) tension. Upon exposure to hypoxia, phosphorylation of eEF2 at Thr(56) occurred rapidly (<15 min) and resulted in modest translational arrest, a fundamental homeostatic response to hypoxia that spares ATP and thus facilitates cell survival. Acute inhibitory eEF2 phosphorylation occurred without ATP depletion or AMP kinase activation. Furthermore, eEF2 phosphorylation was mimicked by prolyl hydroxylase (PHD) inhibition with dimethyloxalylglycine or by selective PHD2 siRNA silencing but was independent of hypoxia-inducible factor α stabilization. Moreover, overexpression of PHD2 blocked hypoxic accumulation of phosphorylated eEF2. Therefore, our findings suggest that eEF2 phosphorylation status (and, as a consequence, translation rate) is controlled by PHD2 activity. They unravel a novel pathway for cell adaptation to hypoxia that could have pathophysiologic relevance in tissue ischemia and cancer.

3 January 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
MBMARIAN Bustamante
MARIAN Bustamante
MGMaría del Pilar Fernández Gil
María del Pilar Fernández Gil
ICItziar Churruca
Itziar Churruca
JMJonatan Miranda
Jonatan Miranda
ALArrate Lasa
Arrate Lasa
ESEdurne Simon
Edurne Simon
The treatment of Celiac disease consists in a strict lifelong gluten-free (GF) diet. As the ingestion of small amounts can have damaging complications, there has been an ongoing discussion regarding the safe threshold for dietary residual gluten. The aim was to analyze the evolution of gluten content in cereal-based GF foodstuffs (n = 3141) from 1998 to 2016 measured by the enzyme-linked immunosorbent assay (ELISA) technique. Eight categories were defined: flours, breakfast cereals/bars, bakery, pasta, breads, dough, snacks, and yeasts, and these were divided into GF labeled-foods (GF-L) or reportedly GF foodstuffs, but not certified (GF-NC). Gluten-detection was decreased over time in line with the evolving European regulations about food information and gluten content claims. This decline started sooner in GF-L products than in GF-NC. As a whole, gluten was detected in 371 samples, with breakfast cereals/bars being the most contaminated group. Snacks and yeasts changed from being high gluten-detected samples to being totally GF over the years. The downside is that, of contaminated samples, those in the low levels of gluten detection range have decreased while flour samples containing over 100 mg/kg gluten have risen in the 2013–2016 period. Obtained data confirm that GF cereal-based foods are becoming safer but gluten control must be maintained.

1 June 2006 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
VNVirginia Navarro
Virginia Navarro
AFAlfredo Fernandez-Quintela
Alfredo Fernandez-Quintela
ICItziar Churruca
Itziar Churruca
MPMaria P. Portillo
Maria P. Portillo